Literature DB >> 10325426

Werner syndrome helicase contains a 5'-->3' exonuclease activity that digests DNA and RNA strands in DNA/DNA and RNA/DNA duplexes dependent on unwinding.

N Suzuki1, M Shiratori, M Goto, Y Furuichi.   

Abstract

We show that WRN helicase contains a unique 5'-->3' exonuclease activity in the N-terminal region. Adeletion mutant lacking 231 N-terminal amino acid residues, made in a baculovirus system, did nothave this activity, while it showed ATPase and DNA helicase activities. This exonuclease activity was co-precipitated with the helicase activity using monoclonal antibodies specific to WRN helicase, indicating that it is an integral component with WRN helicase. The exonuclease in WRN helicase does not digest free single-stranded DNA or RNA, but it digests a strand in the duplex DNA or an RNA strand in a RNA/DNA heteroduplex in a 5'-->3' direction dependent on duplex unwinding. The digestion products were identified as 5'-mononucleotides. Our data show that WRN helicase needs a single-stranded 3' overhang region for efficient binding and unwinding of duplex molecules, while blunt-ended or 5' overhang duplex molecules were hardly unwound. These findings suggest that the WRN helicase and integral 5'-->3' exonuclease activities are involved in preventing a hyper-recombination by resolving entangled structures of DNA and RNA/DNA heteroduplexes that may be generated during rep-lication, repair and/or transcription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325426      PMCID: PMC148803          DOI: 10.1093/nar/27.11.2361

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Ku complex interacts with and stimulates the Werner protein.

Authors:  M P Cooper; A Machwe; D K Orren; R M Brosh; D Ramsden; V A Bohr
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

2.  Potent inhibition of werner and bloom helicases by DNA minor groove binding drugs.

Authors:  R M Brosh; J K Karow; E J White; N D Shaw; I D Hickson; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

3.  The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases.

Authors:  P Mohaghegh; J K Karow; R M Brosh; V A Bohr; I D Hickson
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Telomere repeat DNA forms a large non-covalent complex with unique cohesive properties which is dissociated by Werner syndrome DNA helicase in the presence of replication protein A.

Authors:  I Ohsugi; Y Tokutake; N Suzuki; T Ide; M Sugimoto; Y Furuichi
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

5.  Werner syndrome exonuclease catalyzes structure-dependent degradation of DNA.

Authors:  J C Shen; L A Loeb
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

6.  Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.

Authors:  Yongli Bai; John P Murnane
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

7.  Characterization of the human and mouse WRN 3'-->5' exonuclease.

Authors:  S Huang; S Beresten; B Li; J Oshima; N A Ellis; J Campisi
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

8.  The amino terminus of the Saccharomyces cerevisiae DNA helicase Rrm3p modulates protein function altering replication and checkpoint activity.

Authors:  Jessica B Bessler; Virginia A Zakian
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

9.  Sequence-specific processing of telomeric 3' overhangs by the Werner syndrome protein exonuclease activity.

Authors:  Baomin Li; Sita Reddy; Lucio Comai
Journal:  Aging (Albany NY)       Date:  2009-03-17       Impact factor: 5.682

10.  The Caenorhabditis elegans Werner syndrome protein functions upstream of ATR and ATM in response to DNA replication inhibition and double-strand DNA breaks.

Authors:  Se-Jin Lee; Anton Gartner; Moonjung Hyun; Byungchan Ahn; Hyeon-Sook Koo
Journal:  PLoS Genet       Date:  2010-01-08       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.